Status:
RECRUITING
Prevalence and Trends of Antimicrobial Resistance of Helicobacter Pylori in Korea
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Helicobacter Pylori Infection
Helicobacter Pylori Associated Gastrointestinal Disease
Eligibility:
All Genders
Brief Summary
To assess antimicrobial resistance rates and minimal inhibitory concentrations in H. pylori isolated from patients with upper gastrointestinal disease with long-term period.
Detailed Description
Failure of eradication treatment against Helicobacter pylori (H. pylori) is mainly caused by antimicrobial resistance. However, there is no relevant studies have been conducted on the prevalence and t...
Eligibility Criteria
Inclusion
- Subjects who had a H. pylori infection and had consented to undergo culture analysis via endoscopic resection, in order to determine the minimal inhibitory concentration (MIC) of various antibiotics.
Exclusion
- Patients with a concurrent critical illness, who abused drugs or alcohol, who were pregnant or nursing, or those who had received antibiotics, PPIs, or bismuth salts within 4 weeks, were excluded.
Key Trial Info
Start Date :
July 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2027
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT05247112
Start Date
July 1 2003
End Date
December 31 2027
Last Update
April 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 13620